Boston Scientific Corp. named Michael Mahoney of Johnson & Johnson its next chief executive officer as the world’s second-largest maker of implantable heart devices seeks to expand its product line and return to profitability.
Globalstar Inc., the provider of satellite-phone services that’s traded below $1 since 2011, now offers investors the chance for returns of at least 30 percent in a takeover thanks to its coveted airwaves.
Boston Scientific Corp.’s Watchman improved survival in patients with erratic heart rates after four years, an unexpected finding that may help create a $500 million market, said Chief Executive Officer Michael Mahoney.
Boston Scientific Corp.’s Michael Mahoney, who took the helm yesterday as chief executive officer, says innovation and smooth integration of recent acquisitions will return the company to growth next year.
MetroPCS Communications Inc., the wireless carrier looking to expand, may struggle to become a viable replacement for T-Mobile USA as AT&T Inc. tries to win government approval to buy the company from Deutsche Telekom AG.
Institutional Shareholder Services Inc., an investor advisory firm, recommended against T-Mobile USA Inc.’s merger with MetroPCS Communications Inc., dealing a blow to a transaction that lacks the support of MetroPCS’s biggest owner.
Boston Scientific Corp., the second- biggest maker of heart-rhythm devices, reported profit that beat analysts’ estimates and raised its forecast amid signs that demand for defibrillators and stents is starting to stabilize. The shares rose the most in two years.